Cephalon Challenges Sun's Anti-Epilepsy Generic
Cephalon Inc. hit Sun Pharmaceutical Industries Inc. with a suit in New Jersey federal court Wednesday alleging its attempts to market a generic version of an anti-epilepsy drug infringed a Cephalon...To view the full article, register now.
Already a subscriber? Click here to view full article